Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018.Palmera, Inc, a second Alembic portfolio company, is developing new therapeutic and novel products for the minimally invasive treatment of stroke that have the potential to improve outcome for patients that are currently treated, as well as widen the scope of patients that can benefit from therapy.